The Boston Planning Department has approved 717K SF of new development and a pair of long-term master plans that include a new 300-bed cancer hospital.

The master plans were for Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center, which are partnering to build a new 450K SF cancer hospital at One Joslin Place.

The 14-story hospital project would still have to go through its own review process before construction can start.

Dana-Farber made the pitch to state regulators for the $1.6B expansion at the beginning of the year, the Boston Globe reported. It argued that it would increase its competition and meet expected needs for cancer care locally and nationally.

The institute said it will need approximately 384 inpatient beds by 2032 and pointed to the expansion of competitors like Houston-based MD Anderson and New York City-based Memorial Sloan Kettering, the Globe reported.

The BPD also approved two other institutional master plans for Wentworth Institute of Technology and the Franciscan Children's Hospital, which would create a new inpatient hospital at 30 Warren St. in Brighton. Harvard University got its IMP renewed and extended.

Other development projects approved include Rhino Capital Advisors' conversion of an office building at 110 Canal St. in the West End into a new 82-room boutique hotel.

Related Beal and Dream Development's first phase of the Boston Water and Sewer Commission parking lots in Roxbury was also approved. The project is planned to include 45 income-restricted units at 980 Harrison Ave. The Community Builders Inc. received approval for its redevelopment of the Boston Housing Authority's Faneuil Gardens, which will create 114 income-restricted units.